1-5 of 5
Authors: Ying Cheng
Save search
Sort by
Journal Article

Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer

PDF
Hong Jian and others
The Oncologist, Volume 27, Issue 3, March 2022, Pages 163–e213, https://doi.org/10.1093/oncolo/oyab007
Published: 26 February 2022
Journal Article

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)

PDF
Yihebali Chi and others
The Oncologist, Volume 26, Issue 10, October 2021, Pages e1693–e1703, https://doi.org/10.1002/onco.13857
Published: 25 June 2021
Journal Article

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

PDF
Ai‐Ping Zhou and others
The Oncologist, Volume 24, Issue 8, August 2019, Pages e702–e708, https://doi.org/10.1634/theoncologist.2018-0839
Published: 22 March 2019
Journal Article

Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study

PDF
Shukui Qin and others
The Oncologist, Volume 19, Issue 11, November 2014, Pages 1169–1178, https://doi.org/10.1634/theoncologist.2014-0190
Published: 15 September 2014
Journal Article

The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma

PDF
Jifang Gong and others
The Oncologist, Volume 19, Issue 2, February 2014, Pages 173–174, https://doi.org/10.1634/theoncologist.2013-0137
Published: 23 January 2014